
NMPA approves novel globally trialled therapy before US, Japan, Europe
What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.

Curating from trusted global sources…
108 briefings · “ip”

What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.

Secondary-market bidders are paying premium prices for access to Elon Musk's AI and robotics bets, even as valuations stay murky.

In a Bloomberg Opinion op-ed, Michael Bloomberg argues government ownership incentives would replace regulation and corrupt outcomes.

The open-weight coding model lands on Hugging Face with 1M-token context and benchmark scores that outrun bigger rivals.

Pocketpair’s update is surging on PC, and the platform split is reshaping what “next big IP” looks like.

Cryo Archive is open to all for two weeks, and Bungie also tweaks progression and adds chat moderation.

Xbox’s leadership churn keeps swinging, and the fastest exits are happening inside engineering and product execution.

The timing of the stock reversal and insider selling schedules matters as the next Starship flight approaches.

OpenAI reports a zero-day enabled internet access and a Hugging Face production hack, calling it unprecedented.
New Florida International University simulations suggest mergers are not the universal kill switch for star formation.

Singapore leads with visa-free access to 192 jurisdictions in Henley & Partners' 2026 passport index.

A sudden leadership shake-up follows street protests, with Zelensky replacing a Soviet-trained top commander.